These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8531102)

  • 1. Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys.
    Gatch MB; Negus SS; Butelman ER; Mello NK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1346-54. PubMed ID: 8531102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
    France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
    Baker AK; Hoffmann VL; Meert TF
    Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of cocaine in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK
    Pharmacol Biochem Behav; 1999 Feb; 62(2):291-7. PubMed ID: 9972696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine.
    Paronis CA; Woods JH
    J Pharmacol Exp Ther; 1997 Jul; 282(1):355-62. PubMed ID: 9223574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in opioid antinociception.
    Bartok RE; Craft RM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):769-78. PubMed ID: 9262340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
    Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.
    Brandt MR; Furness MS; Mello NK; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2001 Mar; 296(3):939-46. PubMed ID: 11181927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
    Walker EA; Zernig G; Woods JH
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1345-52. PubMed ID: 7791107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
    Butelman ER; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice.
    O'Neill SJ; Collins MA; Pettit HO; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):271-7. PubMed ID: 9223564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.